SCHEMBL1121875

SCHEMBL1121875

COc1ccc2c(c1OC)C(=O)N1CC(O)C[C@H]1C(=O)N2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
ALDH1A1 P00352 7/20 0.35
KDM4E B2RXH2 4/20 0.35
HSD17B10 Q99714 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35
GFER P55789 1/20 0.35
KMT2A Q03164 1/20 0.35
ACHE P22303 1/20 0.35
MAPT P10636 3/20 0.34
POLB P06746 3/20 0.34
HTR2C P28335 2/20 0.34
HTR2A P28223 1/20 0.34
HTR2B P41595 1/20 0.34
HTT P42858 1/20 0.34
LMNA P02545 2/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1121876 1.00 NPC1 (0.36) NPC1RAB9AALDH1A1KDM4EHSD17B10
SCHEMBL1121820 0.79 ALDH1A1 (0.33) NPC1RAB9AALDH1A1KDM4EHSD17B10
SCHEMBL5962898 0.79 ALDH1A1 (0.33) NPC1RAB9AALDH1A1KDM4EHSD17B10
SCHEMBL12856769 0.77 KDM4E (0.38) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL12715398 0.76 CRBN (0.43) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL29778202 0.75 PDE3B (0.44) ALDH1A1KDM4ESMN1; SMN2HPGDL3MBTL1
SCHEMBL12714533 0.73 CRBN (0.44) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL7265416 0.73 CES1 (0.40) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL13422023 0.71 KDM4E (0.37) ALDH1A1KDM4EMEN1KMT2APOLB
SCHEMBL16067443 0.70 POLB (0.40) KDM4EMEN1KMT2AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575955-B1 PYRROLOBENZODIAZEPINES FOR THE TREATMENT OF PROLIFERATIVE DISEASES SPIROGEN LTD (GB) 2011-02-09 EP disclosed
US-7407951-B2 Pyrrolobenzodiazepines SPIROGEN LIMITED (GB) 2008-08-05 US disclosed
US-7067511-B2 Pyrrolobenzodiazepines SPIROGEN LIMITED (GB) 2006-06-27 US disclosed
US-20060128693-A1 Pyrrolobenzodiazepines MEDIMMUNE LIMITED (GB) 2006-06-15 US disclosed
US-7049311-B1 Pyrrolbenzodiazepines SPIROGEN LIMITED (GB) 2006-05-23 US disclosed
EP-1109812-B1 PYRROLOBENZODIAZEPINES SPIROGEN LTD (GB) 2005-05-04 EP disclosed
EP-1413582-A1 Dimeric pyrrolobenzodiazepines Spirogen Limited (GB) 2004-04-28 EP disclosed
US-20030120069-A1 Pyrrolobenzodiazepines SPIROGEN LIMITED (GB) 2003-06-26 US disclosed
EP-1193270-A2 Pyrrolobenzodiazepines Spirogen Limited (GB) 2002-04-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030120069-A1 Pyrrolobenzodiazepines CNR1, CBX2, CNR2 NPC1 749/4885RAB9A 1745/4885ALDH1A1 4469/4885
US-20060128693-A1 Pyrrolobenzodiazepines CYP2C19, CYP3A7, CYP2E1 NPC1 788/4885RAB9A 3549/4885ALDH1A1 1206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.